Tier 2 — strong
The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
Journal of translational medicine
2024
22(1):225
Bibliography
- PubMed
- PMID 38429794
- PubMed Central
- PMC10908013
- Funding
- Supported through the Foshan Fourteenth Five-Year Plan key-specialty construction program.
- Competing interests
- A complete competing-interest declaration was not available in the accessible source; no absence of conflicts is inferred.
Study snapshot
| Design | Systematic review and meta-analysis |
|---|---|
| Model | Published human studies |
| Sample | 10 randomized trials; 811 participants |
| Intervention | Evidence synthesis; interventions and comparators vary across included studies |
| Duration | No new treatment; included-study durations vary |
| Endpoints | Pooled clinical or metabolic outcomes; Risk of bias and heterogeneity; Adverse-event reporting |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
